You are here
- Home
- Nebuliser Therapy
Nebuliser Therapy
- Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trialJohn Belperio, Tuan Nguyen, David A Lombardi, Maxim Bogus, Valentyn Moskalenko, Dave Singh, Brett Haumann, David L Bourdet, Elad Kaufman, Nathan D Pfeifer, Corbin G Thompson, Jacky Woo, Edmund J Moran, Rajeev SaggarBMJ Open Respiratory Research Jul 2023, 10 (1) e001627; DOI: 10.1136/bmjresp-2023-001627
- Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosisSteven D Nathan, Jurgen Behr, Vincent Cottin, Lisa Lancaster, Peter Smith, CQ Deng, Natalie Pearce, Heidi Bell, Leigh Peterson, Kevin R FlahertyBMJ Open Respiratory Research Jul 2022, 9 (1) e001310; DOI: 10.1136/bmjresp-2022-001310
- In vitro evaluation of disposable transport ventilators with combination aerosol therapyMarc Mac Giolla Eain, Andrew O'Sullivan, Mary Joyce, Ronan MacLoughlinBMJ Open Respiratory Research Mar 2021, 8 (1) e000739; DOI: 10.1136/bmjresp-2020-000739
- Patients’ practices and experiences of using nebuliser therapy in the management of COPD at homeB Alhaddad, F J Smith, T Robertson, G Watman, K M G TaylorBMJ Open Respiratory Research Feb 2015, 2 (1) e000076; DOI: 10.1136/bmjresp-2014-000076
- Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary diseaseS Jarvis, P W Ind, C Thomas, S Goonesekera, R Haffenden, A Abdolrasouli, F Fiorentino, R J ShinerBMJ Open Respiratory Research Feb 2014, 1 (1) e000018; DOI: 10.1136/bmjresp-2013-000018
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)